Submit an abstract by September 26, 2024, to be considered for presentation at the 50th Annual ONS Congress in Denver, CO.
ONS Congress Abstracts 2025
Submit your notification of intent for a position on the ONS Board of Directors today.
ONS Leadership Process
It's not too late to experience the education and resources from ONS Bridge. Register by October 15, 2024, to access the recorded session library through October 22, 2024.
Registration
A clinical decision support (CDS) tool to bring the most recent biomarker advances to the point of care.
Genomics and Precision Oncology Learning LibraryWe are students, clinicians, scientists, educators, and mentors working together to transform the way the world cares for cancer.
Oxaliplatin (Eloxatin®) is a platinum-based drug used since 2002 to treat colorectal cancer. It can cause serious hypersensitivity adverse reactions and has the unique side effect of reversible peripheral sensory neuropathy exacerbated by exposure to cold temperature or objects. It gets its name from its chemical structure, which has an oxalate ligand.
